Cargando…

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era

Detalles Bibliográficos
Autores principales: Gandini, Lucia, Fior, Gabriele, Schibler, Andreas, Obonyo, Nchafatso G., Li Bassi, Gianluigi, Suen, Jacky Y., Fraser, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039681/
https://www.ncbi.nlm.nih.gov/pubmed/36966340
http://dx.doi.org/10.1186/s13054-023-04394-w
_version_ 1784912321386119168
author Gandini, Lucia
Fior, Gabriele
Schibler, Andreas
Obonyo, Nchafatso G.
Li Bassi, Gianluigi
Suen, Jacky Y.
Fraser, John F.
author_facet Gandini, Lucia
Fior, Gabriele
Schibler, Andreas
Obonyo, Nchafatso G.
Li Bassi, Gianluigi
Suen, Jacky Y.
Fraser, John F.
author_sort Gandini, Lucia
collection PubMed
description
format Online
Article
Text
id pubmed-10039681
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100396812023-03-27 Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era Gandini, Lucia Fior, Gabriele Schibler, Andreas Obonyo, Nchafatso G. Li Bassi, Gianluigi Suen, Jacky Y. Fraser, John F. Crit Care Comment BioMed Central 2023-03-25 /pmc/articles/PMC10039681/ /pubmed/36966340 http://dx.doi.org/10.1186/s13054-023-04394-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Comment
Gandini, Lucia
Fior, Gabriele
Schibler, Andreas
Obonyo, Nchafatso G.
Li Bassi, Gianluigi
Suen, Jacky Y.
Fraser, John F.
Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
title Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
title_full Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
title_fullStr Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
title_full_unstemmed Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
title_short Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
title_sort interleukin-6 inhibitors in non-covid-19 ards: analyzing the past to step into the post-covid-19 era
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039681/
https://www.ncbi.nlm.nih.gov/pubmed/36966340
http://dx.doi.org/10.1186/s13054-023-04394-w
work_keys_str_mv AT gandinilucia interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era
AT fiorgabriele interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era
AT schiblerandreas interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era
AT obonyonchafatsog interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era
AT libassigianluigi interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era
AT suenjackyy interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era
AT fraserjohnf interleukin6inhibitorsinnoncovid19ardsanalyzingthepasttostepintothepostcovid19era